Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiformeCorey Smith, Rajiv Khanna, Michelle A. Neller et al.|Journal of Clinical Investigation|2020Cited by 64
Impact of pre‐therapy glioblastoma multiforme microenvironment on clinical response to autologous CMV‐specific T‐cell therapyDavid Walker, Rajiv Khanna, Reshma Shakya et al.|Clinical & Translational Immunology|2019Cited by 12